Coya TherapeuticsCOYA
13F holders, Q2 2024 (June 30)At the end of Q2 2024, 19 institutions reported holding Coya Therapeutics Inc. (COYA) in their 13F filings, unchanged from Q1 2024. 4 opened new positions and 4 sold out. The largest holders were Greenlight Capital (DME Capital Management) ($7.7M), Vanguard Group Inc. ($5.1M) and AIGH Capital Management LLC ($3.9M). 2 famous investors held it, including David Einhorn (0.4% of Greenlight Capital (DME Capital Management)'s portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Coya Therapeutics Inc.
- CUSIP
- 22407B108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $198K |
| Exits | 4 | $1.3M |
All 13F filers, Q1 2024 → Q2 2024: 67,743 shares bought and 138,522 shares sold, net −70,779 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 19 holders
| Greenlight Capital (DME Capital Management) | 0.38% | No change | 1,274,026 | $7.7M |
| Vanguard Group Inc. | 0.00% | Reduce -0.2% | 845,424 | $5.1M |
| AIGH Capital Management LLC | 1.92% | No change | 649,427 | $3.9M |
| Geode Capital Management, LLC | 0.00% | Add +9.4% | 137,824 | $835K |
| CM Management, LLC | 0.56% | No change | 100,000 | $606K |
| BlackRock Inc. | 0.00% | Add +19.6% | 64,578 | $391K |
| State Street Corp. | 0.00% | Reduce -6.9% | 43,000 | $261K |
| Prelude Capital Management, LLC | 0.02% | No change | 35,770 | $217K |
| Royal Bank of Canada | 0.00% | Add +7.1% | 33,698 | $204K |
| Northern Trust Corp. | 0.00% | Reduce -0.1% | 25,450 | $154K |
| Renaissance Technologies | 0.00% | New | 16,700 | $101K |
| Mirador Capital Partners LP | 0.02% | Reduce -4.8% | 14,731 | $89K |
| UBS Group AG | 0.00% | Add +1682.7% | 10,696 | $65K |
| Gilbert & Cook, Inc. | 0.01% | New | 10,000 | $61K |
| Osaic Holdings, Inc. | 0.00% | New | 3,342 | $20K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 2,687 | $16K |
| Morgan Stanley | 0.00% | Add +50.4% | 800 | $5K |
| Bank of America Corp. | 0.00% | Reduce -93.4% | 107 | $648 |
| JPMorgan Chase & Co. | 0.00% | Reduce -94.0% | 32 | $194 |
"% of holder's portfolio" is COYA's weight in each manager's 13F, not the share of Coya Therapeutics Inc. the manager owns.